Prognostic value of automated quantification of 99mTc-sestamibi myocardial perfusion imaging

Journal of Nuclear Medicine

Volumn 46, Issue 2, 2005, Pages 204-211

  Leslie, William D ^a,b,d   Tully, Shawn A ^b   Yogendran, Marina S ^c   Ward, Linda M ^b   Nour, Khaled A ^b   Metge, Colleen J ^a,c  

^a UNIVERSITY OF MANITOBA   (Canada)

^b ST BONIFACE GENERAL HOSPITAL   (Canada)

^c UNIVERSITY OF MANITOBA   (Canada)

^d Department of Medicine ^*  (Canada)

Author keywords

99mTc; Coronary artery disease; Myocardial perfusion imaging; Prognosis; Quantification; Sestamibi

Indexed keywords

METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; DIAGNOSTIC AGENT; RADIOPHARMACEUTICAL AGENT;

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; AUTOMATION; COMPUTER ANALYSIS; CONTROLLED STUDY; FEMALE; FOLLOW UP; HEART DEATH; HEART MUSCLE PERFUSION; HUMAN; IMAGE ANALYSIS; IMAGE QUALITY; MAJOR CLINICAL STUDY; MALE; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; RISK ASSESSMENT; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; CANADA; COMORBIDITY; COMPUTER ASSISTED DIAGNOSIS; CORONARY ARTERY ATHEROSCLEROSIS; EPIDEMIOLOGY; EVALUATION; EXERCISE TEST; HEART; HEART INFARCTION; HOSPITALIZATION; INCIDENCE; METHODOLOGY; MIDDLE AGED; MORTALITY; OBSERVER VARIATION; PREVALENCE; REPRODUCIBILITY; RETROSPECTIVE STUDY; RISK FACTOR; SCINTISCANNING; SENSITIVITY AND SPECIFICITY; STATISTICS; SURVIVAL; VALIDATION STUDY;

CAUSALITY; COMORBIDITY; CORONARY ARTERIOSCLEROSIS; EXERCISE TEST; FEMALE; HEART; HUMANS; IMAGE INTERPRETATION, COMPUTER-ASSISTED; INCIDENCE; MALE; MANITOBA; MIDDLE AGED; MYOCARDIAL INFARCTION; OBSERVER VARIATION; PREVALENCE; PROGNOSIS; RADIOPHARMACEUTICALS; REPRODUCIBILITY OF RESULTS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX; SURVIVAL ANALYSIS; TECHNETIUM TC 99M SESTAMIBI; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 15844424555     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Ritchie JL, Bateman TM, Bonow RO, et al. Guidelines for clinical use of cardiac radionuclide imaging: report of the American College of Cardiology/American Heart Association Task Force on Assessment of Diagnostic and Therapeutic Cardiovascular Procedures (Committee on Radionuclide Imaging), developed in collaboration with the American Society of Nuclear Cardiology. J Am Coll Cardiol. 1995;25:521-547.
2. Hachamovitch R, Berman DS, Kiat H, et al. Exercise myocardial perfusion SPECT in patients without known coronary artery disease: incremental prognostic value and use in risk stratification. Circulation. 1996;93:905-914.
3. Leslie WD, Tully S, Yogendran MD, Ward LM, Nour KA, Metge CJ. Automated quantification of technetium 99m sestamibi myocardial perfusion compared with visual analysis. Nucl Med Commun. 2004;25:833-838.
4. Germano G, Kavanagh PB, Waechter P, et al. A new algorithm for the quantitation of myocardial perfusion SPECT. I. Technical principles and reproducibility. J Nucl Med. 2000;41:712-719.
5. Sharir T, Germano G, Waechter PB, et al. A new algorithm for the quantitation of myocardial perfusion SPECT. II. Validation and diagnostic yield. J Nucl Med. 2000;41:720-727.
6. Berman DS, Kang X, Van Train KF, et al. Comparative prognostic value of automatic quantitative analysis versus semiquantitative visual analysis of exercise myocardial perfusion single-photon emission computed tomography. J Am Coll Cardiol. 1998;32:1987-1995.
7. Choy JB, Leslie WD. Clinical correlates of Tc-99m sestamibi lung uptake. J Nucl Cardiol. 2001;8:639-644.
8. Hachamovitch R, Berman DS, Shaw LJ, et al. Incremental prognostic value of myocardial perfusion single photon emission computed tomography for the prediction of cardiac death: differential stratification for risk of cardiac death and myocardial infarction. Circulation. 1998;97:535-543.
9. Sharir T, Germano G, Kang X, et al. Prediction of myocardial infarction versus cardiac death by gated myocardial perfusion SPECT: risk stratification by the amount of stress-induced ischemia and the poststress ejection fraction. J Nucl Med. 2001;42:831-837.
10. Roos LL, Mustard CA, Nicol JP, et al. Registries and administrative data: organization and accuracy. Med Care. 1993;31:201-212.
11. Roos LL, Sharp SM, Wajda A. Assessing data quality: a computerized approach. Soc Sci Med. 1989;28:175-182.
12. Tu JV, Austin PC, Walld R, Roos L, Agras J, McDonald KM. Development and validation of the Ontario acute myocardial infarction mortality prediction rules. J Am Coll Cardiol. 2001;37:992-997.
13. Blanchard JF, Ludwig S, Wajda A, et al. Incidence and prevalence of diabetes in Manitoba, 1986-1991. Diabetes Care. 1996;19:807-811.
14. Brown KA. Prognostic value of myocardial perfusion imaging: state of the art and new developments. J Nucl Cardiol. 1996;3(6 part 1):516-537.
15. 99mTc-tetrofosmin SPECT imaging: results from the multicenter registry of 4,728 patients. J Nucl Med. 2003;44:134-139.
16. Berman DS, Hachamovitch R, Kiat H, et al. Incremental value of prognostic testing in patients with known or suspected ischemic heart disease: a basis for optimal utilization of exercise technetium-99m sestamibi myocardial perfusion single-photon emission computed tomography. J Am Coll Cardiol. 1995;26:639-647.
17. Travin MI, Dessouki A, Cameron T, Heller GV. Use of exercise technetium-99m sestamibi SPECT imaging to detect residual ischemia and for risk stratification after acute myocardial infarction. Am J Cardiol. 1995;75:665-669.
18. Heller GV, Herman SD, Travin MI, Baron JI, Santos-Ocampo C, McClellan JR. Independent prognostic value of intravenous dipyridamole with technetium-99m sestamibi tomographic imaging in predicting cardiac events and cardiac-related hospital admissions. J Am Coll Cardiol 1995;26:1202-1208.